Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Family with sequence similarity 220 member B, pseudogene (FAM220BP), encodes a sequence highly homologous to the protein FAM220B but is classified as a pseudogene, meaning it is not generally believed to produce a functional protein product[3][7]. Annotated in databases with aliases including C9orf51 and "Protein FAM220B pseudogene," it is located in humans on chromosome 9. Protein products have been produced for research purposes using recombinant techniques but functional activity and biological roles have not been established[1][5]. Pseudogenes are generally considered non-functional genomic elements, though recent research suggests some may be transcribed and even translated under certain circumstances; however, there is no definitive evidence that FAM220BP is actively involved in biological processes or disease[7]. Based on current knowledge, it is not considered a therapeutic target, receptor, enzyme, or transporter. If referenced as a target, this is likely a mistake or based on outdated/incomplete knowledge. If you are seeking information for drug discovery, receptor pharmacology, functional genomics, or therapeutic targeting, this entry is unsuitable, as it represents a pseudogene with no established functional protein product or disease association[3][7]. All classification fields for function, disease, drugs, mechanisms, biomarkers, and safety should return null or empty unless new experimental evidence emerges.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Family with sequence similarity 220 member B, pseudogene (FAM220BP).